hero image
Stuart Gold, M.D. - UNC-Chapel Hill. Chapel Hill, NC, US

Stuart Gold, M.D. Stuart Gold, M.D.

Professor and Chief, Department of Pediatrics | UNC-Chapel Hill

Chapel Hill, NC, UNITED STATES

Dr. Stuart Gold specializes in Pediatric Hematology-Oncology.

Media

Publications:

Documents:

Photos:

Videos:

real doctors, real people - Stuart Gold Interview with Stuart Gold, MD Pediatric Hematology Area in N.C. Cancer Hospital

Audio:

Social

Biography

Dr. Stuart Gold and the Division of Pediatric Hematology-Oncology specialize in the diagnosis, treatment, and management of malignancies in children and adolescents. UNC Pediatrics and the Division of Hematology-Oncology are partnered with the Children’s Oncology Group (COG), as part of an international consortium. COG unites leading pediatric institutions in the United States and abroad to conduct clinical trials and laboratory research related to childhood cancers.

Industry Expertise (3)

Research

Medical/Dental Practice

Education/Learning

Areas of Expertise (5)

Oncology

Hematology

Pediatrics

Pediatric Oncology

Leukemia

Media Appearances (4)

Bell at UNC Paediatric Cancer Center Rings in Hope

ABC 11  online

2015-09-11

UNC Pediatric Oncology division chief Dr. Stuart Gold said the sound of the bell ringing gives children in treatment something to look forward to. "I think the kids are going to say 'look at little Johnny just rang the bell, in six months I'll be able to ring the bell!'" Gold said. "And I think you know, we try to give all of our families hope."...

view more

Reelin' for Research does it again

Carteret County News-Times  online

2015-05-06

The doctor entrusted by the organization, Dr. Stuart Gold, is chief of pediatric hematology and oncology at UNC-Chapel Hill and director of the same department at the Children’s Hospital. He has been a partner with the charity organization since Montana approached him six years ago. Then, Montana was only 28 years old and still mourning the death of his father, Tony Montana, from cancer in 2009. He came to Gold with the idea of starting up a nonprofit fishing tournament that would benefit cancer research, particularly for children. He dialed in on Morehead City for the location at which to make it all possible...

view more

The Good Hurt

SB Nation  online

2013-04-03

When they got to UNC they skipped registration and went straight into a room where they met Dr. Stuart Gold, considered one of the best pediatric oncologists on the East Coast. He told them that Ray had acute lymphoblastic leukemia—blood cancer that causes production of immature white blood cells to get out of hand. They build up in the bone marrow until there’s no room for healthy white blood cells, nor red blood cells and platelets, which are crucial to help the body fight infection, transport oxygen and stop bleeding. Leukemia itself doesn’t kill someone, but it destroys the body in so many ways that it eventually can’t function—it leads to massive fluid buildup that suffocates organs, eradicates the immune system so badly that the simplest sickness is devastating, and wrecks the healthy blood that carries oxygen around the body. In time, the body just gives out...

view more

Fayetteville brothers fight cancer

WRAL.com  online

2011-02-07

North Carolina Cancer Hospital at UNC pediatric oncologist Dr. Stuart Gold said the family's battle with cancer is very rare. "It's incredibly rare to have two kids with cancer in the same family. There are some types of cancer that do run in the family, but not in these particular areas," he said. There is a history of cancer in both parents' families, but geneticists have not been able to definitively cite that as a cause with either child. Gold said their prognosis is good, and most children beat cancer...

view more

Articles (5)

β-Blockers for Infantile Hemangiomas: A Single-Institution Experience

Sage Journals

2011 Propranolol has become first-line therapy for the treatment of infantile hemangiomas in many centers. Of 302 children with hemangiomas seen at the University of North Carolina from 2008 through 2010, 15.6% were treated with oral propranolol alone, 5.6% with topical timolol (a propranolol derivative) alone, and 2.3% with both. The use of these agents increased over time from 7% of patients seen in 2008 to 54% of patients first seen in 2010. Starting doses of propranolol ranged from 0.25 to 1 mg/kg/d, with target doses of 1 to 4 mg/kg/d. Serious side effects, noted in 6/54 (10.9%) patients, included somnolence, bradycardia, hypotension, hypoglycemia, and mottling of extremities.The authors confirm the variation in use of propranolol for vascular lesions and extend experience with timolol. They suggest daily home monitoring of patients for the first 2 weeks of initiating or increasing doses. Frequent feeding of infants and young children on this drug is recommended.

view more

Weaver Syndrome and Neuroblastoma

Journal of Pediatric Hematology/Oncology

2008 Overgrowth syndromes such as Beckwith-Wiedemann syndrome, Sotos syndrome, and Weaver syndrome have an increased risk of neoplasia. Two previous cases of neuroblastoma have been reported in children with Weaver syndrome. We present a third description of a patient with Weaver syndrome and neuroblastoma. In a child with phenotypic characteristics consistent with Weaver syndrome, evaluation for neuroblastoma should be considered.

view more

Clinicopathologic Analysis of HER-2/neu Immunoexpression among Various Histologic Subtypes and Grades of Osteosarcoma

Modern Pathology

2001 ABSTRACT: Overexpression of the HER-2/neu oncogene appears to have prognostic significance in breast cancer. Recently, some have reported a relationship between increased immunohistochemical expression in osteosarcoma and poor clinical outcome. Despite limited data, a pilot trial of Herceptin, which targets the oncogene product, has been initiated for the therapy of some metastatic osteosarcomas (CCG-P9852)...

view more

Social skills and psychological adjustment of child and adolescent cancer survivors

Psycho-Oncology

2000 Social skills and psychological adjustment for survivors of childhood cancer were investigated. Cancer survivors included 42 children and adolescents ranging in age at evaluation from 6 to 18 years with a mean age of 13.1 years. Measures included teacher and parent ratings of social skills and adjustment and parent ratings of family functioning. The findings showed that social skills and psychological adjustment as rated by both parents and teachers were primarily associated with academic functioning. In addition, family cohesiveness was found to account for nearly one third of the variance in survivors' adjustment when rated by teachers, and length of time off treatment accounted for a significant percentage of the variance in children's adjustment when rated by parents...

view more

Bone density in survivors of childhood malignancies.

Journal of Pediatric Hematology / Oncology

1996 PURPOSE: The purpose of this study was to assess bone mineralization in survivors of childhood malignancies...

view more